Korean J Intern Med.  2006 Dec;21(4):287-290. 10.3904/kjim.2006.21.4.287.

Skin Necrosis after a Low-Dose Vasopressin Infusion through a Central Venous Catheter for Treating Septic Shock

Affiliations
  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. sbhong@amc.seoul.kr

Abstract

This is a report on a case of severe skin necrosis in a vasodilatory septic shock patient after the infusion of low-dose vasopressin through a central venous catheter. An 84-year-old male was hospitalized for edema on both legs at Asan Medical Center, Seoul, Korea. On hospital day 8, the patient began to complain of dyspnea and he subsequently developed severe septic shock caused by E. coli. After being transferred to the medical intensive care unit, his hypotension, which was refractory to norepinephrine, was controlled by an infusion of low-dose vasopressin (0.02 unit/min) through a central venous catheter into the right subclavian vein. After the infusion of low-dose vasopressin, severe skin necrosis with bullous changes developed, necessitating discontinuation of the low-dose vasopressin infusion. The patient expired from refractory septic shock. Although low-dose vasopressin can control hypotension in septic shock patients, low-dose vasopressin must be used with caution because ischemic complications such as skin necrosis can develop even with administration through a central venous catheter.

Keyword

Arginine vasopressin; Septic shock; Necrosis

MeSH Terms

Vasopressins/administration & dosage/*adverse effects/therapeutic use
Vasoconstrictor Agents/administration & dosage/*adverse effects/therapeutic use
Skin/*drug effects/*pathology
Shock, Septic/*drug therapy
Necrosis/chemically induced/pathology
Male
Infusions, Intravenous
Humans
Fatal Outcome
Dose-Response Relationship, Drug
Catheterization, Central Venous
Aged, 80 and over
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr